Head-to-head · Cost-Efficiency Index
Metaboost Rx vs TRT Kingdom
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Metaboost Rx
Shoppers who don't mind entering an eligibility funnel to get a firm, itemized quote.
Visit Metaboost RxTRT Kingdom
Shoppers open to a TRT-focused telehealth brand's GLP-1 line who are comfortable committing to a 4-month prepay term for the advertised rate.
Visit TRT KingdomThe verdict
Metaboost Rx and TRT Kingdom tie on the Cost-Efficiency Index at 54/100, so neither wins outright on the numbers. For most shoppers we'd start with Metaboost Rx (ranked #359, a hair above #365) — Shoppers who don't mind entering an eligibility funnel to get a firm, itemized quote. But TRT Kingdom is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Metaboost Rx.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Metaboost Rx | TRT Kingdom |
|---|---|---|
| Cost-Efficiency Index | 54/100 | 54/100 |
| Semaglutide / mo | $249/mo (starting dose, compounded) | $149/mo (compounded) |
| Tirzepatide / mo | $299/mo (starting dose, compounded) | $199/mo (compounded) |
| Semaglutide / yr (modeled) | $2,988 | $1,788 |
| Tirzepatide / yr (modeled) | $3,588 | $2,388 |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #359 | #365 |
Metaboost Rx
54/100Where the value is
- Publishes at least headline starting prices on the homepage, unlike some peers that hide all numbers
- '$0 if not approved' guarantee reduces risk of a wasted consultation fee
- Offers a microdose GLP-1 tier alongside standard semaglutide/tirzepatide
The tradeoffs
- Homepage price and product-page pricing don't match up -- dose tiers and confirmed rates are never shown together
- No named medical director or compounding pharmacy partner disclosed
TRT Kingdom
54/100Where the value is
- Confirmed, real compounded GLP-1 (semaglutide) and GLP-1/GIP (tirzepatide) products exist and are separately priced, despite the company's TRT-focused branding
- Named clinical group and Chief Medical Officer (REM Health Medical Group, P.A.; Daniel Olivero) plus two named nurse practitioners
- LegitScript verification badge displayed
The tradeoffs
- The advertised $149/$199 monthly rates require committing to a 4-month plan; no month-to-month or shorter-term price is published
- Pharmacy is described only as 'an FDA registered pharmacy in the USA' -- no name, state, or accreditation given
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.